tiprankstipranks
Vivesto AB ADR (OASMY)
OTHER OTC:OASMY
US Market

Vivesto AB ADR (OASMY) Stock Price & Analysis

49 Followers

OASMY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.02 - $0.13
Previous Close$0.02
Volume250.00
Average Volume (3M)225.00
Market Cap
$16.27M
Enterprise Value$1.29M
Total Cash (Recent Filing)kr164.24M
Total Debt (Recent Filing)kr6.24M
Price to Earnings (P/E)-0.3
Beta0.39
May 23, 2024
EPS EstimateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding179,347,818
10 Day Avg. Volume37
30 Day Avg. Volume225
Standard Deviation13.63
R-Squared0.00921
Alpha1.66
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

0.00%0.00%0.02%99.98%
0.00%
Insiders
0.00%
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

OASMY FAQ

What was Vivesto AB ADR’s price range in the past 12 months?
Vivesto AB ADR lowest stock price was $0.02 and its highest was $0.13 in the past 12 months.
    What is Vivesto AB ADR’s market cap?
    Currently, no data Available
    When is Vivesto AB ADR’s upcoming earnings report date?
    Vivesto AB ADR’s upcoming earnings report date is May 23, 2024 which is in 56 days.
      How were Vivesto AB ADR’s earnings last quarter?
      Vivesto AB ADR released its earnings results on Feb 22, 2024. The company reported -$0.034 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.034.
        Is Vivesto AB ADR overvalued?
        According to Wall Street analysts Vivesto AB ADR’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Vivesto AB ADR pay dividends?
          Vivesto AB ADR pays a Notavailable dividend of <$0.01 which represents an annual dividend yield of N/A. See more information on Vivesto AB ADR dividends here
            What is Vivesto AB ADR’s EPS estimate?
            Vivesto AB ADR’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Vivesto AB ADR have?
            Vivesto AB ADR has 179,347,820 shares outstanding.
              What happened to Vivesto AB ADR’s price movement after its last earnings report?
              Vivesto AB ADR reported an EPS of -$0.034 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Vivesto AB ADR?
                Currently, no hedge funds are holding shares in OASMY
                ---

                Vivesto AB ADR Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -81.30%
                12-Months-Change

                Fundamentals

                Return on Equity
                -47.67%
                Trailing 12-Months
                Asset Growth
                -35.89%
                Trailing 12-Months

                Company Description

                Vivesto AB ADR

                Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Takeda Pharmaceutical Company
                AstraZeneca
                Sanofi
                GlaxoSmithKline
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis